查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1964091

生物樣本採集試劑盒市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、應用、最終用途、地區和競爭對手分類，2021-2031年

Biological Sample Collection Kits Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product, By Application, By End-Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物檢體採集試劑盒市場預計將從 2025 年的 84.9 億美元成長到 2031 年的 128.6 億美元，複合年成長率為 7.17%。

這些試劑盒包含一套完整的儀器和保存試劑，旨在採集、穩定和運輸血液、唾液和組織等檢體，用於診斷和研究。推動市場成長的主要因素是全球慢性病和感染疾病需要廣泛的臨床檢測和持續監測。此外，生物銀行基礎設施的快速發展以及遠端患者監護的日益普及，也推動了對高效便捷、支援分散式檢查模式的採集解決方案的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 84.9億美元
市場規模：2031年 128.6億美元
複合年成長率：2026-2031年 7.17%
成長最快的細分市場 棉花棒
最大的市場 北美洲

為了佐證檢體處理的巨大需求，歐洲醫療技術協會（MedTech Europe）預測，到2024年，歐洲醫療技術市場規模將達到約1,700億歐元，其中體外診斷將成為最大的細分市場。儘管需求強勁，但維持低溫運輸物流的高成本和複雜性已成為市場擴張的重大障礙。運輸過程中的溫度波動會對檢體完整性和診斷準確性構成嚴重威脅，因此，嚴格的溫度控制成為限制市場成長的因素。

市場促進因素

全球感染疾病和慢性病發病率的上升趨勢是生物檢體採集試劑盒市場的主要驅動力，這使得頻繁的診斷篩檢和持續的疾病管理變得尤為重要。隨著長期健康問題的日益普遍，醫療保健系統越來越依賴有效的檢體收集工具來進行患者照護和早期檢測。例如，美國疾病管制與預防中心（CDC）在2025年4月報告稱，到2023年，76.4%的美國成年人將至少患有一種慢性病，這證實了需要定期體檢的人群數量龐大。這項負擔促使人們加大對相關研究的資金投入，截至2025年10月，美國國家癌症研究所2025會計年度的預算維持在72.2億美元，這保證了臨床試驗和預防性篩檢所需耗材的持續需求。

同時，居家檢測和消費者導向的直接檢測的快速成長正在重塑整個產業格局，使診斷流程去中心化。患者擴大選擇微創的自採血方法，這些方法既私密又便捷，從而減少了對傳統採血中心的需求。專注於遠距物流的數位醫療服務提供者的成功凸顯了這一轉變。 《商業與金融》雜誌2025年3月報道稱，LetsGetChecked在2024年的銷售額達到了5億美元，反映出消費者接受度的激增。這一趨勢促使製造商開發出方便用戶使用型試劑盒，以確保檢體在標準郵寄運輸過程中保持穩定，從而推動市場向傳統臨床環境之外拓展。

市場挑戰

維持低溫運輸物流的高昂成本和複雜性是生物檢體採集試劑盒市場成長的主要障礙。確保檢體完整性需要從採集到檢查室的無縫、溫控供應鏈，這需要昂貴的專用包裝、冷藏運輸和持續監控。這些經濟投入推高了診斷檢測的整體成本，限制了成本敏感市場和基礎設施不足地區的試劑盒普及。因此，對這種資源密集型物流的依賴阻礙了分散式檢查的擴充性，使得醫療機構難以證明為防止檢體劣化所需的高昂營運成本的合理性。

該市場對物流的嚴格要求體現在國際運輸樞紐的嚴格標準。 2024年，國際航空運輸協會（IATA）指出，全球已有超過500個站點通過了其專門的醫藥物流檢驗計畫。如此龐大的認證網路凸顯了該行業面臨的營運挑戰，因為檢體必須經過這些監管嚴格的樞紐才能確保其有效性。任何此類專業基礎設施的缺陷或偏差都可能導致溫度偏差，進而造成檢體失效和經濟損失。這些都將直接阻礙市場滲透。

市場趨勢

向永續和可生物分解材料的轉變正在從根本上改變市場上的製造和物流策略。在日益嚴格的環境法規和企業淨零排放目標的推動下，製造商正在加速用生物基聚合物取代一次性塑膠，並透過採用常溫運輸解決方案來減少對低溫運輸的依賴。這一轉變得到了「實驗室永續發展運動」的支持，該運動倡導環保採購，以應對診斷測試對環境的影響。根據英國英國化學學會 (RSC) 2024 年 9 月發布的一份報告，全球實驗室每年產生約 550 萬噸塑膠廢棄物，這一數字正在加速整個行業對可回收和廢棄物的檢體運輸設計的呼籲。

同時，液態生物檢體和非侵入性採樣技術的快速普及推動了對專門用於保存細胞遊離DNA (cfDNA) 的血液採集裝置的需求。與標準靜脈穿刺裝置不同，這些先進的試劑盒使用專有的防腐劑在室溫下穩定循環腫瘤DNA，防止基因組分解。這為腫瘤學領域提供了一種替代侵入性組織切片檢查的方法。血液基因組檢測數量的成長也印證了這個趨勢。 2024年11月，Natera公司報告稱，僅在第三季度就進行了約137,100例腫瘤檢測，與去年同期相比成長了54.4%，這表明非侵入性檢測工具在臨床實踐中得到了大規模應用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：生物樣本採集試劑盒的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 分裝產品（拭子、病毒保存培養基、血液採集試劑盒）
    • 透過應用（診斷、調查）
    • 依最終用途（醫院/診所、診斷中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生物樣本採集試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物樣本採集試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生物樣本採集試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物樣本採集試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美生物樣本採集試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球生物樣本採集試劑盒市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Seegene Inc.
  • Medline Industries, Inc.
  • Altona Diagnostics GmbH
  • CTK Biotech, Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23895

The Global Biological Sample Collection Kits Market is projected to expand from USD 8.49 Billion in 2025 to USD 12.86 Billion by 2031, registering a CAGR of 7.17%. These kits consist of comprehensive assemblies of instruments and preservation reagents designed to collect, stabilize, and transport specimens like blood, saliva, and tissue for diagnostic and research purposes. Market growth is primarily fueled by the increasing global prevalence of chronic and infectious diseases, which require extensive clinical testing and continuous surveillance. Furthermore, the rapid development of biobanking infrastructure and a rising preference for remote patient monitoring have bolstered demand for efficient, user-friendly collection solutions that support decentralized testing models.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.49 Billion
Market Size 2031USD 12.86 Billion
CAGR 2026-20317.17%
Fastest Growing SegmentSwabs
Largest MarketNorth America

Highlighting the scale of specimen processing needs, MedTech Europe estimated the European medical technology market at approximately €170 billion in 2024, with in vitro diagnostics standing out as the largest sector. Despite this strong demand, market expansion faces a significant hurdle due to the high costs and complexities associated with maintaining cold chain logistics. Temperature fluctuations during transit pose a serious risk to sample integrity and diagnostic accuracy, making the requirement for strict temperature control a limiting factor for broader market reach.

Market Driver

The increasing global prevalence of infectious diseases and chronic conditions acts as a major driver for the biological sample collection kits market, necessitating frequent diagnostic screening and ongoing disease management. As long-term health issues become more common, healthcare systems depend on effective specimen collection tools for patient care and early detection. For example, the Centers for Disease Control and Prevention reported in April 2025 that 76.4% of US adults had at least one chronic condition in 2023, underscoring the vast population needing regular diagnostics. This burden has led to strong financial backing for research; the National Cancer Institute's budget for fiscal year 2025 was maintained at $7.22 billion as of October 2025, ensuring continued demand for supplies used in clinical trials and preventive screening.

Concurrently, the industry is being reshaped by the rapid growth of home-based and direct-to-consumer testing, which decentralizes the diagnostic process. Patients are increasingly choosing minimally invasive, self-administered collection methods that provide privacy and convenience, reducing the need for traditional phlebotomy centers. This shift is highlighted by the success of digital health providers specializing in remote logistics; Business & Finance reported in March 2025 that LetsGetChecked achieved a turnover of $500 million in 2024, reflecting surging consumer adoption. This trend pushes manufacturers to develop user-friendly kits that maintain sample stability during standard mail transport, extending market reach beyond traditional clinical settings.

Market Challenge

The significant expense and complexity involved in maintaining cold chain logistics represent a major obstacle to the growth of the biological sample collection kits market. Ensuring sample integrity demands an unbroken, temperature-controlled supply chain from collection to the laboratory, requiring costly specialized packaging, refrigerated transport, and continuous monitoring. This financial requirement raises the overall cost of diagnostic testing, limiting the accessibility of these kits in cost-sensitive markets or regions with inadequate infrastructure. Consequently, reliance on such resource-intensive logistics hinders the scalability of decentralized testing, as healthcare providers find it difficult to justify the high operational costs needed to prevent specimen degradation.

The logistical rigidity necessary for this market is underscored by the strict standards applied to global transport hubs. In 2024, the International Air Transport Association noted that over 500 stations globally were certified under its specialized pharmaceutical logistics validation program. This need for a vast, certified network highlights the operational challenges facing the industry, as samples must traverse these highly regulated nodes to ensure viability. Any gap or deviation in this specialized infrastructure risks temperature excursions, resulting in sample invalidation and financial losses that directly impede broader market adoption.

Market Trends

The move toward sustainable and biodegradable materials is fundamentally transforming manufacturing and logistics strategies within the market. Driven by tighter environmental regulations and corporate net-zero targets, manufacturers are increasingly replacing single-use plastics with bio-based polymers and adopting ambient shipping solutions to reduce reliance on cold chains. This shift is supported by the laboratory sustainability movement, which encourages eco-friendly procurement to address the environmental impact of diagnostics. According to the Royal Society of Chemistry in September 2024, global laboratories generate an estimated 5.5 million metric tons of plastic waste annually, a figure that is spurring an industry-wide push for recyclable and waste-reducing specimen transport designs.

At the same time, the rapid uptake of liquid biopsy and non-invasive sampling methods is driving demand for specialized blood collection devices tailored to preserve cell-free DNA (cfDNA). Unlike standard venipuncture tools, these advanced kits utilize proprietary preservatives to stabilize circulating tumor DNA at room temperature, preventing genomic degradation and offering an alternative to invasive tissue biopsies in oncology. This trend is demonstrated by the rising volume of blood-based genomic tests; Natera, Inc. reported in November 2024 that it performed approximately 137,100 oncology tests in the third quarter alone, marking a 54.4% year-over-year increase and indicating massive clinical adoption of these non-invasive tools.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Seegene Inc.
  • Medline Industries, Inc.
  • Altona Diagnostics GmbH
  • CTK Biotech, Inc

Report Scope

In this report, the Global Biological Sample Collection Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Sample Collection Kits Market, By Product

  • Swabs
  • Viral Transport Media
  • Blood Collection Kits

Biological Sample Collection Kits Market, By Application

  • Diagnostics
  • Research

Biological Sample Collection Kits Market, By End-Use

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others

Biological Sample Collection Kits Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biological Sample Collection Kits Market.

Available Customizations:

Global Biological Sample Collection Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Sample Collection Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Swabs, Viral Transport Media, Blood Collection Kits)
    • 5.2.2. By Application (Diagnostics, Research)
    • 5.2.3. By End-Use (Hospitals and Clinics, Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Biological Sample Collection Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Sample Collection Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Canada Biological Sample Collection Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Mexico Biological Sample Collection Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-Use

7. Europe Biological Sample Collection Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biological Sample Collection Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-Use
    • 7.3.2. France Biological Sample Collection Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-Use
    • 7.3.3. United Kingdom Biological Sample Collection Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-Use
    • 7.3.4. Italy Biological Sample Collection Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Biological Sample Collection Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-Use

8. Asia Pacific Biological Sample Collection Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biological Sample Collection Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Biological Sample Collection Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-Use
    • 8.3.3. Japan Biological Sample Collection Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-Use
    • 8.3.4. South Korea Biological Sample Collection Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Biological Sample Collection Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-Use

9. Middle East & Africa Biological Sample Collection Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biological Sample Collection Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-Use
    • 9.3.2. UAE Biological Sample Collection Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-Use
    • 9.3.3. South Africa Biological Sample Collection Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-Use

10. South America Biological Sample Collection Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biological Sample Collection Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Colombia Biological Sample Collection Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-Use
    • 10.3.3. Argentina Biological Sample Collection Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biological Sample Collection Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. QIAGEN NV
  • 15.3. F. Hoffmann-La Roche Ltd
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Becton, Dickinson and Company
  • 15.6. Laboratory Corporation of America Holdings
  • 15.7. Seegene Inc.
  • 15.8. Medline Industries, Inc.
  • 15.9. Altona Diagnostics GmbH
  • 15.10. CTK Biotech, Inc

16. Strategic Recommendations

17. About Us & Disclaimer